Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Illumina Inc
(NQ:
ILMN
)
376.35
USD
+5.31 (+1.43%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Illumina Inc
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale
January 11, 2021
Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides a...
From
Business Wire News Releases
Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling
January 11, 2021
With genetic sequencing at the forefront of precision medicine, Illumina (NASDAQ: ILMN) is pleased to announce a portfolio of new and expanded oncology partnerships that further the company’s...
From
Business Wire News Releases
Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
January 11, 2021
From
GlobeNewswire News Releases
Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure
January 05, 2021
Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel strains of SARS-CoV-2...
From
Business Wire News Releases
Illumina to Webcast Upcoming Investor Conference Presentations
December 22, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
From
Business Wire News Releases
Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing
December 08, 2020
Illumina and Harvard Pilgrim Health Care expand access to whole-genome sequencing for genetic disease testing.
From
Business Wire News Releases
Companion Diagnostics Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2020-2025 | ExpertMarketResearch.com
December 01, 2020
Tags
Financial Content
Research Newswire
Reportedtimes
From
iCrowdNewswire
Illumina to Webcast Upcoming Investor Conference Presentation
November 18, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
From
Business Wire News Releases
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
November 17, 2020
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes.
From
PR Newswire
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
November 12, 2020
. Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1...
From
Business Wire News Releases
Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA
November 12, 2020
Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation of an alliance with Microsoft to advance the field of DNA data...
From
Business Wire News Releases
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
October 29, 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020.
From
Business Wire News Releases
IDbyDNA and Illumina Launch New Rapid Test to Better Detect Respiratory Co-Infections and Identify Antibiotic Resistant Pathogens
October 15, 2020
New Panel to Provide Support During Onset of Flu Season in the Midst of the COVID-19 Pandemic
From
PR Newswire
Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020
September 28, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020.
From
Business Wire News Releases
Illumina to Webcast Upcoming Investor Conference Presentation
September 23, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
From
Business Wire News Releases
Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
September 21, 2020
Illumina, Inc. (NASDAQ: ILMN) and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which...
From
Business Wire News Releases
Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
August 25, 2020
Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
From
Business Wire News Releases
Wouter Meuleman Promoted to Partner of Illumina Ventures
August 11, 2020
Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, Inc. (NASDAQ: ILMN), today announced the promotion of Wouter Meuleman to Partner.
From
PR Newswire
Illumina to Webcast Upcoming Investor Conference Presentation
August 07, 2020
UBS Genomics 2.0 and Medtech Innovations Summit
From
Business Wire News Releases
Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome
August 06, 2020
Illumina, Inc. (Nasdaq:ILMN). The power to make bigger discoveries is here with the launch of NovaSeqTM 6000 v1.5 Reagent Kit. The new NovaSeq 6000 v1.5 Reagent Kits aim to make whole genome sequencing...
From
Business Wire News Releases
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020
August 06, 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2020.
From
Business Wire News Releases
Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020
July 16, 2020
Q2 2020 Earnings Release Date Announcement
From
Business Wire News Releases
Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
July 08, 2020
Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite. TruSight...
From
Business Wire News Releases
Illumina Accelerator Welcomes First Global Cohort of Genomics Startups
June 23, 2020
Illumina, Inc. (NASDAQ:ILMN) has selected seven early-stage companies to join the first global cohort of Illumina Accelerator, the company creation engine focused on partnering with entrepreneurs to...
From
Business Wire News Releases
Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
June 17, 2020
Illumina, Inc. (NASDAQ: ILMN) is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that...
From
Business Wire News Releases
Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies
June 16, 2020
Illumina, Inc. (NASDAQ: ILMN) today announced that the U.S. District Court for the Northern District of California issued a preliminary injunction order against several BGI companies, including MGI...
From
Business Wire News Releases
Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
June 09, 2020
Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use...
From
Business Wire News Releases
Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment
May 28, 2020
Strategic investment from Illumina and others enables large-scale COVID-19 testing using next generation sequencing
From
PR Newswire
Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
May 18, 2020
Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the global, national and local relief efforts of our customers, employees and communities, as we unite to combat COVID-19. Giving back is in our...
From
Business Wire News Releases
Natera and Illumina Settle Patent Dispute
May 18, 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, and Illumina Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing platforms, today announced that they...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.